Concomitant utilization of XANAX with strong CYP3A inhibitors provides a profound impact on the clearance of alprazolam, resulting in greater concentrations of alprazolam and increased danger of adverse reactions [see Scientific Pharmacology (12.3)]. Avoidance or administration It grew to become